2025-04-08 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis

**0) Executive Summary:**

Intuitive Surgical Inc. (ISRG) is a leading medical device company focused on robotic-assisted surgery.  The company demonstrates significant outperformance compared to the S&P 500 (VOO), exhibiting high growth but also substantial volatility. While recent indicators show some weakening momentum, long-term prospects remain positive based on the provided data.


**1) Performance Comparison:**

Intuitive Surgical (ISRG) has significantly outperformed the S&P 500 (VOO).  The cumulative return for ISRG is 184.15%, while VOO's is 73.15%. This represents a difference of 111.0 percentage points, placing it in the 68.2nd percentile of its historical range of outperformance against the S&P 500 (max 166.1%, min -7.3%).

The provided alpha and beta analysis shows high CAGR (Compound Annual Growth Rate) and varying levels of Maximum Drawdown (MDD). Alpha consistently above 0 signifies outperformance, while beta over 1 suggests higher volatility than the market (as expected in a growth stock).  The increasing Beta from 2015-2023 reflects increased market sensitivity.  The high MDD in 2020-2022 and 2022-2024 are important observations.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 71.0% | 8.7% | 42.0% | -0.0 | 43.6 |
| 2016-2018  | 83.0% | 8.8% | 65.0% | 0.0 | 57.2 |
| 2017-2019  | 87.0% | 9.8% | 57.0% | 0.4 | 70.6 |
| 2018-2020  | 50.0% | 12.2% | 19.0% | 0.5 | 97.7 |
| 2019-2021  | 95.0% | 12.2% | 21.0% | 0.5 | 128.7 |
| 2020-2022  | 13.0% | 63.2% | 4.0% | 0.5 | 95.1 |
| 2021-2023  | 20.0% | 63.9% | -1.0 | 1.0 | 120.9 |
| 2022-2024  | 97.0% | 70.8% | 77.0% | 1.0 | 187.0 |
| 2023-2025  | 91.0% | 70.8% | 77.0% | 0.8 | 166.1 |


**2) Recent Price Movement:**

* **Closing Price:** $463.62
* **5-day Moving Average:** $482.64
* **20-day Moving Average:** $492.35
* **60-day Moving Average:** $548.61

The stock is currently trading below its 5, 20, and 60-day moving averages, suggesting a downtrend.  The recent price increase of $2.67 (from $451.58) might indicate a minor short-term bounce, but the overall trend is bearish.

**3) Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4792 (High Risk) - Indicates elevated market risk.
* **RSI:** 43.09 (Below 50) - Suggests the stock is oversold.
* **PPO:** -0.28 (Negative) - Indicates bearish momentum.
* **Relative Strength Index (RSI):** 43.09  which is below 50 and suggests that the stock is oversold. 
* **20-day Relative Strength:** -0.9  This indicates a recent downward trend in the stock's performance relative to the market.
* **Expected Return:** 32.4% (over S&P 500) - Suggests significant potential for outperformance over the long term (2+ years). The relatively high expected return despite the recent price drop could be due to investor confidence in ISRG's long-term growth potential.

**4) Recent Earnings Analysis:**

The provided earnings data shows steady growth in revenue and EPS (Earnings Per Share) with some minor fluctuations.


| Date       | EPS    | Revenue      |
|------------|--------|---------------|
| 2024-10-18 | $1.59  | $2.04 B       |
| 2024-07-19 | $1.48  | $2.01 B       |
| 2024-04-19 | $1.54  | $1.89 B       |
| 2023-10-20 | $1.18  | $1.74 B       |
| 2024-10-18 | $1.18  | $1.74 B       |  *(Duplicate Entry - Potentially an error in the data)*


**5) Financial Information:**

Both revenue and profitability metrics demonstrate strong and consistent performance with some minor fluctuations.   The Revenue continues to exhibit a growth trajectory, despite some quarterly fluctuations, indicating a healthy and expanding market for Intuitive Surgical's products.  Profit margins are consistently above 65%, showing great operational efficiency.


**Revenue and Profitability:**

| Quarter     | Revenue    | Profit Margin |
|-------------|------------|---------------|
| 2024-12-31 | $2.41B     | 68.04%        |
| 2024-09-30 | $2.04B     | 67.41%        |
| 2024-06-30 | $2.01B     | 68.30%        |
| 2024-03-31 | $1.89B     | 65.87%        |
| 2023-12-31 | $1.93B     | 66.24%        |


**Capital and Profitability:**

Equity shows consistent growth. Return on Equity (ROE) demonstrates some fluctuation but is generally healthy.


| Quarter     | Equity (B) | ROE (%) |
|-------------|------------|---------|
| 2024-12-31 | $16.43     | 4.17    |
| 2024-09-30 | $15.58     | 3.63    |
| 2024-06-30 | $14.71     | 3.58    |
| 2024-03-31 | $13.96     | 3.90    |
| 2023-12-31 | $13.31     | 4.56    |



**6) Overall Analysis:**

ISRG exhibits strong long-term growth potential, significantly outperforming the S&P 500.  However, it also displays considerable volatility, as evidenced by the high beta and recent price action.  The current technical indicators suggest a short-term bearish trend, although the stock is currently trading in oversold territory.  The high expected return and strong financial performance suggest that ISRG remains a compelling long-term investment for those with a higher risk tolerance.  Careful monitoring of market conditions and earnings reports is advised due to the observed volatility.  The duplicate entry in the earnings data should be investigated for accuracy.
